Hardy Reed’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,027
Closed -$1.98M 269
2026
Q1
$1.98M Sell
4,027
-1,069
-21% -$580K 0.14% 63
2025
Q4
$2.95M Buy
5,096
+16
+0.3% +$9.05K 0.21% 48
2025
Q3
$2.46M Buy
5,080
+20
+0.4% +$9.31K 0.18% 49
2025
Q2
$2.05M Buy
5,060
+2,490
+97% +$1.04M 0.16% 57
2025
Q1
$1.28M Hold
2,570
0.11% 83
2024
Q4
$1.34M Hold
2,570
0.12% 77
2024
Q3
$1.59M Buy
2,570
+11
+0.4% +$6.51K 0.14% 68
2024
Q2
$1.42M Buy
+2,559
New +$1.47M 0.14% 73

Other funds holding TMO

Hardy Reed's TMO Position: Q2 2026 in Review

Hardy Reed sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 4,027 shares — an estimated $1.98M sold.

Hardy Reed first reported a position in TMO in Q2 2024 and held it in 8 quarters. The position peaked at $2.95M in Q4 2025. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Hardy Reed reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Hardy Reed sold 4,027 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.98M.
  • Hardy Reed first reported a position in Thermo Fisher Scientific in Q2 2024 and held it in 8 quarters.
  • Hardy Reed's Thermo Fisher Scientific position peaked at $2.95M in Q4 2025.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Hardy Reed's 13F filing for Q2 2026, filed 3 Aug 2026.